Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Navigating Cancer Challenges with Onconil 550mg Capsule
In the realm of cancer treatment, Onconil 550mg Capsule stands as a stalwart ally, addressing various cancers such as breast cancer, lung cancer, and colon cancer. At its core lies the active ingredient, imatinib, a tyrosine kinase inhibitor renowned for its efficacy in impeding cancer cell growth.
Decoding the Mechanism of Onconil 550mg Capsule:
Inhibition of Cancer Cell Enzymes: Onconil 550mg Capsule orchestrates its therapeutic prowess by inhibiting specific enzymes vital for the growth and proliferation of cancer cells. This strategic interference holds the potential to curtail or arrest the development and dissemination of cancer cells within the body.
Utilizing Onconil 550mg Capsule: A Strategic Approach to Cancer Treatment
Indications for Use:
Leukaemia
Gastrointestinal Stromal Tumours (GISTs)
Post-Surgery Cancer Prevention
Side Effects of Onconil 550mg Capsule:
While Onconil 550mg Capsule champions the cause of cancer treatment, it may accompany certain side effects that warrant attention and monitoring:
Stomach Discomfort: Patients may experience stomach pain, nausea, and vomiting.
Gastrointestinal Impact: Constipation or diarrhea may manifest.
Neurological Effects: Headache and dizziness may be observed.
Musculoskeletal Reactions: Joint or muscle soreness can occur.
Dermatological Responses: Skin conditions like itching, rash, or dryness may manifest.
Fluid Retention: Swelling or fluid retention may be apparent.
General Fatigue: Weakness and exhaustion may impact individuals.